Viatris - Company Profile
All the data and insights you need on Viatris in one report.
- • Save hours of research time and resources with our up-to-date Viatris Strategy Report
- • Understand Viatris's position in the market, performance, and strategic initiatives
- • Gain competitive edge and increase your chances of success
Viatris Competitors
| Competitor | Headquarters | No. of Employees | Revenue | Entity Type |
|---|---|---|---|---|
Pfizer | United States of America | 79,000 | $51.75B | Public |
AbbVie | United States of America | 47,000 | $56.2B | Public |
Johnson & Johnson | United States of America | 132,200 | $94.9B | Public |
Novartis | Switzerland | 110,000 | $48.3B | Public |
Merck & Co. | United States of America | 74,000 | $48.2B | Public |
AstraZeneca | United Kingdom | 76,600 | $44.4B | Public |
Roche | Switzerland | 97,700 | $68B | Public |
GSK (GlaxoSmithKline) | United Kingdom | 99,000 | $46.8B | Public |
Sanofi | France | 100,000 | $43.9B | Public |
Bristol-Myers Squibb | United States of America | 30,000 | $46.1B | Public |
Amgen | United States of America | 23,000 | $26B | Public |
Eli Lilly | United States of America | 35,000 | $28.5B | Public |
Teva Pharmaceutical Industries | Israel | 38,000 | $18.7B | Public |
Sun Pharmaceutical Industries | India | 31,000 | $4.9B | Public |
Takeda Pharmaceutical Company | Japan | 50,000 | $30.8B | Public |
Overview of Viatris's competitor analysis
Viatris operates in a highly competitive pharmaceutical industry with several major players. The leading competitors include Pfizer, AbbVie, and Johnson & Johnson, each commanding significant market share and extensive research capabilities. Companies like Novartis and Merck & Co. bring strong innovation pipelines to the market. As the sector continues to evolve, traditional pharmaceutical giants such as GSK and Sanofi maintain robust portfolios across numerous therapeutic areas. This competitive landscape pushes Viatris to continuously innovate and seek strategic partnerships, emphasizing the importance of adaptability and resource efficiency in a diverse marketplace.
What are Viatris's key strengths compared to competitors?
FAQs
Pfizer
AbbVie
Johnson & Johnson
Novartis
Merck & Co.
AstraZeneca
Roche
GSK (GlaxoSmithKline)
Sanofi
Bristol-Myers Squibb
Amgen
Eli Lilly
Teva Pharmaceutical Industries
Sun Pharmaceutical Industries
Takeda Pharmaceutical Company
Overview of Viatris competitor analysis
Viatris operates in a highly competitive pharmaceutical industry with several major players. The leading competitors include Pfizer, AbbVie, and Johnson & Johnson, each commanding significant market share and extensive research capabilities. Companies like Novartis and Merck & Co. bring strong innovation pipelines to the market. As the sector continues to evolve, traditional pharmaceutical giants such as GSK and Sanofi maintain robust portfolios across numerous therapeutic areas. This competitive landscape pushes Viatris to continuously innovate and seek strategic partnerships, emphasizing the importance of adaptability and resource efficiency in a diverse marketplace.